Michael A. Barry - Publications

Virology and Gene Therapy College of Medicine - Mayo Clinic 
Virology Biology, Molecular Biology, Genetics, Cell Biology

95 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Nguyen TV, Crosby CM, Heller GJ, Mendel ZI, Barry ME, Barry MA. Oncolytic adenovirus Ad657 for systemic virotherapy against prostate cancer. Oncolytic Virotherapy. 7: 43-51. PMID 29765912 DOI: 10.2147/OV.S155946  0.48
2018 Matteson NL, Barry MA, Reddy VS. Structure-based assessment of protein-protein interactions and accessibility of protein IX in adenoviruses with implications for antigen display. Virology. 516: 102-107. PMID 29331865 DOI: 10.1016/j.virol.2018.01.007  0.4
2017 Nguyen TV, Barry ME, Turner MA, Crosby CM, Trujillo MA, Morris JC, Barry MA. Comparison of Liver Detargeting Strategies for Systemic Therapy with Oncolytic Adenovirus Serotype 5. Biomedicines. 5. PMID 28796161 DOI: 10.3390/biomedicines5030046  0.48
2017 Yu X, Veesler D, Campbell MG, Barry ME, Asturias FJ, Barry MA, Reddy VS. Cryo-EM structure of human adenovirus D26 reveals the conservation of structural organization among human adenoviruses. Science Advances. 3: e1602670. PMID 28508067 DOI: 10.1126/sciadv.1602670  0.4
2017 Crosby CM, Barry MA. Transgene Expression and Host Cell Responses to Replication-Defective, Single-Cycle, and Replication-Competent Adenovirus Vectors. Genes. 8. PMID 28218713 DOI: 10.3390/genes8020079  0.48
2016 Crosby CM, Matchett WE, Anguiano-Zarate SS, Parks CA, Weaver EA, Pease LR, Webby RJ, Barry MA. Replicating Single-cycle Adenovirus Vectors Generate Amplified Influenza Vaccine Responses. Journal of Virology. PMID 27807231 DOI: 10.1128/JVI.00720-16  0.48
2016 Couturier J, Agarwal N, Nehete PN, Baze WB, Barry MA, Jagannadha Sastry K, Balasubramanyam A, Lewis DE. Infectious SIV resides in adipose tissue and induces metabolic defects in chronically infected rhesus macaques. Retrovirology. 13: 30. PMID 27117277 DOI: 10.1186/s12977-016-0260-2  0.76
2016 Nguyen TV, Heller GJ, Barry ME, Crosby CM, Turner MA, Barry MA. Evaluation of polymer shielding for adenovirus serotype 6 (Ad6) for systemic virotherapy against human prostate cancers. Molecular Therapy Oncolytics. 3. PMID 26900598 DOI: 10.1038/mto.2015.21  0.48
2016 Barry MA. Adenoviral Vector Targeting via Mitigation of Liver Sequestration Adenoviral Vectors For Gene Therapy: Second Edition. 293-317. DOI: 10.1016/B978-0-12-800276-6.00011-5  0.76
2015 Kang L, Grande JP, Hillestad ML, Croatt AJ, Barry MA, Katusic ZS, Nath KA. A New Model of an Arteriovenous Fistula in Chronic Kidney Disease in the Mouse: Beneficial Effects of Upregulated Heme Oxygenase-1. American Journal of Physiology. Renal Physiology. ajprenal.00288.2015. PMID 26672617 DOI: 10.1152/ajprenal.00288.2015  0.76
2015 Crosby CM, Weaver EA, Khare R, Barry MA. A Novel Codon-optimized SIV Gag-pol Immunogen for Gene-based Vaccination. Virology Reports. 5: 47-55. PMID 26550557 DOI: 10.1016/j.virep.2015.03.002  0.76
2015 Turner MA, Middha S, Hofherr SE, Barry MA. Comparison of the Life Cycles of Genetically Distant Species C and Species D Human Adenoviruses Ad6 and Ad26 in Human Cells. Journal of Virology. 89: 12401-17. PMID 26423951 DOI: 10.1128/JVI.01534-15  0.76
2015 Weaver EA, Camacho ZT, Hillestad ML, Crosby CM, Turner MA, Guenzel AJ, Fadel HJ, Mercier GT, Barry MA. Mucosal vaccination by adenoviruses displaying reovirus sigma 1. Virology. 482: 60-6. PMID 25827529 DOI: 10.1016/j.virol.2015.02.050  0.76
2015 Kang L, Hillestad ML, Grande JP, Croatt AJ, Barry MA, Farrugia G, Katusic ZS, Nath KA. Induction and functional significance of the heme oxygenase system in pathological shear stress in vivo. American Journal of Physiology. Heart and Circulatory Physiology. 308: H1402-13. PMID 25820397 DOI: 10.1152/ajpheart.00882.2014  0.76
2015 Guenzel AJ, Collard R, Kraus JP, Matern D, Barry MA. Long-term sex-biased correction of circulating propionic acidemia disease markers by adeno-associated virus vectors. Human Gene Therapy. 26: 153-60. PMID 25654275 DOI: 10.1089/hum.2014.126  0.76
2015 Crosby CM, Nehete P, Sastry KJ, Barry MA. Amplified and persistent immune responses generated by single-cycle replicating adenovirus vaccines. Journal of Virology. 89: 669-75. PMID 25355873 DOI: 10.1128/JVI.02184-14  0.76
2015 Tonne JM, Sakuma T, Munoz-Gomez M, El Khatib M, Barry MA, Kudva YC, Ikeda Y. Beta cell regeneration after single-round immunological destruction in a mouse model. Diabetologia. 58: 313-23. PMID 25338552 DOI: 10.1007/s00125-014-3416-4  0.76
2014 Singh S, Nehete PN, Yang G, He H, Nehete B, Hanley PW, Barry MA, Sastry KJ. Enhancement of Mucosal Immunogenicity of Viral Vectored Vaccines by the NKT Cell Agonist Alpha-Galactosylceramide as Adjuvant. Vaccines. 2: 686-706. PMID 25553254 DOI: 10.3390/vaccines2040686  0.76
2014 Singh S, Yang G, Byrareddy SN, Barry MA, Sastry KJ. Natural killer T cell and TLR9 agonists as mucosal adjuvants for sublingual vaccination with clade C HIV-1 envelope protein. Vaccine. 32: 6934-40. PMID 25444819 DOI: 10.1016/j.vaccine.2014.10.051  0.76
2014 Guenzel AJ, Hillestad ML, Matern D, Barry MA. Effects of adeno-associated virus serotype and tissue-specific expression on circulating biomarkers of propionic acidemia. Human Gene Therapy. 25: 837-43. PMID 25046265 DOI: 10.1089/hum.2014.012  0.76
2014 Crosby CM, Barry MA. IIIa deleted adenovirus as a single-cycle genome replicating vector. Virology. 462: 158-65. PMID 24996029 DOI: 10.1016/j.virol.2014.05.030  0.76
2014 Camacho ZT, Turner MA, Barry MA, Weaver EA. CD46-mediated transduction of a species D adenovirus vaccine improves mucosal vaccine efficacy. Human Gene Therapy. 25: 364-74. PMID 24635714 DOI: 10.1089/hum.2013.215  0.76
2013 Weaver EA, Barry MA. Low seroprevalent species D adenovirus vectors as influenza vaccines. Plos One. 8: e73313. PMID 23991187 DOI: 10.1371/journal.pone.0073313  0.76
2013 Weaver EA, Nehete PN, Nehete BP, Yang G, Buchl SJ, Hanley PW, Palmer D, Montefiori DC, Ferrari G, Ng P, Sastry KJ, Barry MA. Comparison of systemic and mucosal immunization with helper-dependent adenoviruses for vaccination against mucosal challenge with SHIV. Plos One. 8: e67574. PMID 23844034 DOI: 10.1371/journal.pone.0067574  0.76
2013 Tonne JM, Sakuma T, Deeds MC, Munoz-Gomez M, Barry MA, Kudva YC, Ikeda Y. Global gene expression profiling of pancreatic islets in mice during streptozotocin-induced β-cell damage and pancreatic Glp-1 gene therapy. Disease Models & Mechanisms. 6: 1236-45. PMID 23828045 DOI: 10.1242/dmm.012591  0.76
2013 Guenzel AJ, Hofherr SE, Hillestad M, Barry M, Weaver E, Venezia S, Kraus JP, Matern D, Barry MA. Generation of a hypomorphic model of propionic acidemia amenable to gene therapy testing. Molecular Therapy : the Journal of the American Society of Gene Therapy. 21: 1316-23. PMID 23648696 DOI: 10.1038/mt.2013.68  0.76
2013 Khare R, Hillestad ML, Xu Z, Byrnes AP, Barry MA. Circulating antibodies and macrophages as modulators of adenovirus pharmacology. Journal of Virology. 87: 3678-86. PMID 23325678 DOI: 10.1128/JVI.01392-12  0.76
2012 Hillestad ML, Guenzel AJ, Nath KA, Barry MA. A vector-host system to fingerprint virus tropism. Human Gene Therapy. 23: 1116-26. PMID 22834781 DOI: 10.1089/hum.2011.116  0.76
2012 Sakuma T, Barry MA, Ikeda Y. Lentiviral vectors: basic to translational. The Biochemical Journal. 443: 603-18. PMID 22507128 DOI: 10.1042/BJ20120146  0.76
2012 Cummins NW, Weaver EA, May SM, Croatt AJ, Foreman O, Kennedy RB, Poland GA, Barry MA, Nath KA, Badley AD. Heme oxygenase-1 regulates the immune response to influenza virus infection and vaccination in aged mice. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 26: 2911-8. PMID 22490782 DOI: 10.1096/fj.11-190017  0.76
2012 Weaver EA, Mercier GT, Gottschalk S, Barry MA. T-cell-biased immune responses generated by a mucosally targeted adenovirus-σ1 vaccine Mucosal Immunology. 5: 311-319. PMID 22377931 DOI: 10.1038/mi.2012.11  0.76
2012 Khare R, Reddy VS, Nemerow GR, Barry MA. Identification of adenovirus serotype 5 hexon regions that interact with scavenger receptors. Journal of Virology. 86: 2293-301. PMID 22156515 DOI: 10.1128/JVI.05760-11  0.76
2012 Barry MA, May S, Weaver EA. Imaging luciferase-expressing viruses. Methods in Molecular Biology (Clifton, N.J.). 797: 79-87. PMID 21948470 DOI: 10.1007/978-1-61779-340-0_6  0.76
2012 Barry MA, Weaver EA, Chen CY. Mining the adenovirus "virome" for systemic oncolytics. Current Pharmaceutical Biotechnology. 13: 1804-8. PMID 21740366 DOI: 10.2174/138920112800958823  0.76
2012 Barry MA. Response to Adhikary et al Virology. 424: 2. DOI: 10.1016/j.virol.2011.10.013  0.76
2011 Chen CY, Senac JS, Weaver EA, May SM, Jelinek DF, Greipp P, Witzig T, Barry MA. Species D adenoviruses as oncolytics against B-cell cancers. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 6712-22. PMID 21890454 DOI: 10.1158/1078-0432.CCR-11-0968  0.76
2011 Chen CY, Weaver EA, Khare R, May SM, Barry MA. Mining the adenovirus virome for oncolytics against multiple solid tumor types. Cancer Gene Therapy. 18: 744-50. PMID 21886190 DOI: 10.1038/cgt.2011.47  0.76
2011 Weaver EA, Chen CY, May SM, Barry ME, Barry MA. Comparison of adenoviruses as oncolytics and cancer vaccines in an immunocompetent B cell lymphoma model. Human Gene Therapy. 22: 1095-100. PMID 21770794 DOI: 10.1089/hum.2011.071  0.48
2011 Khare R, May SM, Vetrini F, Weaver EA, Palmer D, Rosewell A, Grove N, Ng P, Barry MA. Generation of a Kupffer cell-evading adenovirus for systemic and liver-directed gene transfer. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 1254-62. PMID 21505422 DOI: 10.1038/mt.2011.71  0.76
2011 Weaver EA, Rubrum AM, Webby RJ, Barry MA. Protection against divergent influenza H1N1 virus by a centralized influenza hemagglutinin. Plos One. 6: e18314. PMID 21464940 DOI: 10.1371/journal.pone.0018314  0.76
2011 Khare R, Chen CY, Weaver EA, Barry MA. Advances and future challenges in adenoviral vector pharmacology and targeting. Current Gene Therapy. 11: 241-58. PMID 21453281 DOI: 10.2174/156652311796150363  0.76
2011 Hofherr SE, Adams KE, Chen CY, May S, Weaver EA, Barry MA. Real-time dynamic imaging of virus distribution in vivo. Plos One. 6: e17076. PMID 21347236 DOI: 10.1371/journal.pone.0017076  0.76
2011 Weaver EA, Hillestad ML, Khare R, Palmer D, Ng P, Barry MA. Characterization of species C human adenovirus serotype 6 (Ad6). Virology. 412: 19-27. PMID 21251688 DOI: 10.1016/j.virol.2010.10.041  0.76
2011 Sakuma T, Tonne JM, Squillace KA, Ohmine S, Thatava T, Peng KW, Barry MA, Ikeda Y. Early events in retrovirus XMRV infection of the wild-derived mouse Mus pahari. Journal of Virology. 85: 1205-13. PMID 21084477 DOI: 10.1128/JVI.00886-10  0.76
2011 Chandler RJ, Chandrasekaran S, Carrillo-Carrasco N, Senac JS, Hofherr SE, Barry MA, Venditti CP. Adeno-associated virus serotype 8 gene transfer rescues a neonatal lethal murine model of propionic acidemia. Human Gene Therapy. 22: 477-81. PMID 20950151 DOI: 10.1089/hum.2010.164  0.76
2011 Barry MA. Recombinant vector vaccines for the prevention and treatment of HIV infection Drugs of the Future. 36: 833-845. DOI: 10.1358/dof.2011.036.11.1688501  0.76
2010 Barry MA, Weaver EA, Hofherr SE. Rescue, amplification, purification, and PEGylation of replication defective first-generation adenoviral vectors. Methods in Molecular Biology (Clifton, N.J.). 651: 227-39. PMID 20686969 DOI: 10.1007/978-1-60761-786-0_13  0.76
2010 Chen CY, May SM, Barry MA. Targeting adenoviruses with factor x-single-chain antibody fusion proteins. Human Gene Therapy. 21: 739-49. PMID 20331369 DOI: 10.1089/hum.2009.190  0.76
2010 Senac JS, Doronin K, Russell SJ, Jelinek DF, Greipp PR, Barry MA. Infection and killing of multiple myeloma by adenoviruses. Human Gene Therapy. 21: 179-90. PMID 19788385 DOI: 10.1089/hum.2009.082  0.76
2009 Weaver EA, Nehete PN, Nehete BP, Buchl SJ, Palmer D, Montefiori DC, Ng P, Sastry KJ, Barry MA. Protection against Mucosal SHIV Challenge by Peptide and Helper-Dependent Adenovirus Vaccines. Viruses. 1: 920. PMID 20107521 DOI: 10.3390/v1030920  0.76
2009 Shashkova EV, May SM, Barry MA. Characterization of human adenovirus serotypes 5, 6, 11, and 35 as anticancer agents. Virology. 394: 311-20. PMID 19765790 DOI: 10.1016/j.virol.2009.08.038  0.76
2009 Shashkova EV, May SM, Doronin K, Barry MA. Expanded anticancer therapeutic window of hexon-modified oncolytic adenovirus. Molecular Therapy : the Journal of the American Society of Gene Therapy. 17: 2121-30. PMID 19755961 DOI: 10.1038/mt.2009.217  0.76
2009 Barry MA, Hofherr SE, Chen CY, Senac JS, Hillestad ML, Shashkova EV. Systemic delivery of therapeutic viruses. Current Opinion in Molecular Therapeutics. 11: 411-20. PMID 19649986  0.76
2009 Doronin K, Shashkova EV, May SM, Hofherr SE, Barry MA. Chemical modification with high molecular weight polyethylene glycol reduces transduction of hepatocytes and increases efficacy of intravenously delivered oncolytic adenovirus. Human Gene Therapy. 20: 975-88. PMID 19469693 DOI: 10.1089/hum.2009.028  0.76
2009 Poland GA, Barry MA. Common cold, uncommon variation. The New England Journal of Medicine. 360: 2245-6. PMID 19458372 DOI: 10.1056/NEJMcibr0902053  0.76
2009 Weaver EA, Nehete PN, Buchl SS, Senac JS, Palmer D, Ng P, Sastry KJ, Barry MA. Comparison of replication-competent, first generation, and helper-dependent adenoviral vaccines. Plos One. 4: e5059. PMID 19333387 DOI: 10.1371/journal.pone.0005059  0.76
2009 Tian J, Xu Z, Smith JS, Hofherr SE, Barry MA, Byrnes AP. Adenovirus activates complement by distinctly different mechanisms in vitro and in vivo: indirect complement activation by virions in vivo. Journal of Virology. 83: 5648-58. PMID 19321608 DOI: 10.1128/JVI.00082-09  0.76
2009 Hofherr SE, Senac JS, Chen CY, Palmer DJ, Ng P, Barry MA. Short-term rescue of neonatal lethality in a mouse model of propionic acidemia by gene therapy. Human Gene Therapy. 20: 169-80. PMID 19025475 DOI: 10.1089/hum.2008.158  0.76
2008 Weaver EA, Barry MA. Effects of shielding adenoviral vectors with polyethylene glycol on vector-specific and vaccine-mediated immune responses. Human Gene Therapy. 19: 1369-82. PMID 18778197 DOI: 10.1089/hgt.2008.091  0.76
2008 Shashkova EV, Doronin K, Senac JS, Barry MA. Macrophage depletion combined with anticoagulant therapy increases therapeutic window of systemic treatment with oncolytic adenovirus. Cancer Research. 68: 5896-904. PMID 18632644 DOI: 10.1158/0008-5472.CAN-08-0488  0.76
2008 Cattaneo R, Miest T, Shashkova EV, Barry MA. Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded. Nature Reviews. Microbiology. 6: 529-40. PMID 18552863 DOI: 10.1038/nrmicro1927  0.76
2008 Hofherr SE, Shashkova EV, Weaver EA, Khare R, Barry MA. Modification of adenoviral vectors with polyethylene glycol modulates in vivo tissue tropism and gene expression. Molecular Therapy : the Journal of the American Society of Gene Therapy. 16: 1276-82. PMID 18461056 DOI: 10.1038/mt.2008.86  0.76
2008 Kalyuzhniy O, Di Paolo NC, Silvestry M, Hofherr SE, Barry MA, Stewart PL, Shayakhmetov DM. Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivo Proceedings of the National Academy of Sciences of the United States of America. 105: 5483-5488. PMID 18391209 DOI: 10.1073/pnas.0711757105  0.76
2008 Saraf A, Hacker MC, Sitharaman B, Grande-Allen KJ, Barry MA, Mikos AG. Synthesis and conformational evaluation of a novel gene delivery vector for human mesenchymal stem cells. Biomacromolecules. 9: 818-27. PMID 18247565 DOI: 10.1021/bm701146f  0.76
2007 Mercier GT, Nehete PN, Passeri MF, Nehete BN, Weaver EA, Templeton NS, Schluns K, Buchl SS, Sastry KJ, Barry MA. Oral immunization of rhesus macaques with adenoviral HIV vaccines using enteric-coated capsules. Vaccine. 25: 8687-701. PMID 18063450 DOI: 10.1016/j.vaccine.2007.10.030  0.76
2007 Hofherr SE, Mok H, Gushiken FC, Lopez JA, Barry MA. Polyethylene glycol modification of adenovirus reduces platelet activation, endothelial cell activation, and thrombocytopenia. Human Gene Therapy. 18: 837-48. PMID 17767399 DOI: 10.1089/hum.2007.0051  0.76
2007 Campos SK, Barry MA. Current advances and future challenges in Adenoviral vector biology and targeting. Current Gene Therapy. 7: 189-204. PMID 17584037 DOI: 10.2174/156652307780859062  0.76
2007 Adams KE, Ke S, Kwon S, Liang F, Fan Z, Lu Y, Hirschi K, Mawad ME, Barry MA, Sevick-Muraca EM. Comparison of visible and near-infrared wavelength-excitable fluorescent dyes for molecular imaging of cancer. Journal of Biomedical Optics. 12: 024017. PMID 17477732 DOI: 10.1117/1.2717137  0.76
2006 Marsh MP, Campos SK, Baker ML, Chen CY, Chiu W, Barry MA. Cryoelectron microscopy of protein IX-modified adenoviruses suggests a new position for the C terminus of protein IX. Journal of Virology. 80: 11881-6. PMID 16987967 DOI: 10.1128/JVI.01471-06  0.76
2006 Chen Z, Mok H, Pflugfelder SC, Li DQ, Barry MA. Improved transduction of human corneal epithelial progenitor cells with cell-targeting adenoviral vectors. Experimental Eye Research. 83: 798-806. PMID 16793039 DOI: 10.1016/j.exer.2006.03.023  0.76
2006 Kasper FK, Jerkins E, Tanahashi K, Barry MA, Tabata Y, Mikos AG. Characterization of DNA release from composites of oligo(poly(ethylene glycol) fumarate) and cationized gelatin microspheres in vitro. Journal of Biomedical Materials Research. Part A. 78: 823-35. PMID 16741980 DOI: 10.1002/jbm.a.30736  0.76
2006 Kasper FK, Young S, Tanahashi K, Barry MA, Tabata Y, Jansen JA, Mikos AG. Evaluation of bone regeneration by DNA release from composites of oligo(poly(ethylene glycol) fumarate) and cationized gelatin microspheres in a critical-sized calvarial defect. Journal of Biomedical Materials Research. Part A. 78: 335-42. PMID 16639744 DOI: 10.1002/jbm.a.30698  0.76
2006 Menezes KM, Mok HS, Barry MA. Increased transduction of skeletal muscle cells by fibroblast growth factor-modified adenoviral vectors. Human Gene Therapy. 17: 314-20. PMID 16544980 DOI: 10.1089/hum.2006.17.314  0.76
2006 Campos SK, Barry MA. Comparison of adenovirus fiber, protein IX, and hexon capsomeres as scaffolds for vector purification and cell targeting. Virology. 349: 453-62. PMID 16504233 DOI: 10.1016/j.virol.2006.01.032  0.76
2006 Andersson HA, Singh RA, Barry MA. Activation of refractory T cell responses against hepatitis C virus core protein by ablation of interfering hydrophobic domains. Molecular Therapy : the Journal of the American Society of Gene Therapy. 13: 338-46. PMID 16242998 DOI: 10.1016/j.ymthe.2005.09.005  0.76
2005 Ghosh D, Barry MA. Selection of muscle-binding peptides from context-specific peptide-presenting phage libraries for adenoviral vector targeting. Journal of Virology. 79: 13667-72. PMID 16227286 DOI: 10.1128/JVI.79.21.13667-13672.2005  0.76
2005 Andersson HA, Passeri MF, Barry MA. Rad23 as a reciprocal agent for stimulating or repressing immune responses. Human Gene Therapy. 16: 634-41. PMID 15916488 DOI: 10.1089/hum.2005.16.634  0.76
2005 Kasper FK, Seidlits SK, Tang A, Crowther RS, Carney DH, Barry MA, Mikos AG. In vitro release of plasmid DNA from oligo(poly(ethylene glycol) fumarate) hydrogels. Journal of Controlled Release : Official Journal of the Controlled Release Society. 104: 521-39. PMID 15911051 DOI: 10.1016/j.jconrel.2005.03.008  0.76
2005 Mok H, Palmer DJ, Ng P, Barry MA. Evaluation of polyethylene glycol modification of first-generation and helper-dependent adenoviral vectors to reduce innate immune responses. Molecular Therapy : the Journal of the American Society of Gene Therapy. 11: 66-79. PMID 15585407 DOI: 10.1016/j.ymthe.2004.09.015  0.76
2004 Campos SK, Barry MA. Rapid construction of capsid-modified adenoviral vectors through bacteriophage lambda Red recombination. Human Gene Therapy. 15: 1125-30. PMID 15610612 DOI: 10.1089/hum.2004.15.1125  0.76
2004 McGuire MJ, Sykes KF, Samli KN, Timares L, Barry MA, Stemke-Hale K, Tagliaferri F, Logan M, Jansa K, Takashima A, Brown KC, Johnston SA. A library-selected, Langerhans cell-targeting peptide enhances an immune response. Dna and Cell Biology. 23: 742-52. PMID 15585132 DOI: 10.1089/1044549042531396  0.76
2004 Singh RA, Barry MA. Repertoire and immunofocusing of CD8 T cell responses generated by HIV-1 gag-pol and expression library immunization vaccines. Journal of Immunology (Baltimore, Md. : 1950). 173: 4387-93. PMID 15383568  0.76
2004 Andersson HA, Barry MA. Maximizing antigen targeting to the proteasome for gene-based vaccines. Molecular Therapy : the Journal of the American Society of Gene Therapy. 10: 432-46. PMID 15336644 DOI: 10.1016/j.ymthe.2004.05.035  0.76
2004 Barry MA, Howell DP, Andersson HA, Chen JL, Singh RA. Expression library immunization to discover and improve vaccine antigens. Immunological Reviews. 199: 68-83. PMID 15233727 DOI: 10.1111/j.0105-2896.2004.00143.x  0.76
2004 Campos SK, Parrott MB, Barry MA. Avidin-based targeting and purification of a protein IX-modified, metabolically biotinylated adenoviral vector. Molecular Therapy : the Journal of the American Society of Gene Therapy. 9: 942-54. PMID 15194061 DOI: 10.1016/j.ymthe.2004.03.006  0.76
2004 Blum JS, Temenoff JS, Park H, Jansen JA, Mikos AG, Barry MA. Development and characterization of enhanced green fluorescent protein and luciferase expressing cell line for non-destructive evaluation of tissue engineering constructs. Biomaterials. 25: 5809-19. PMID 15172493 DOI: 10.1016/j.biomaterials.2004.01.035  0.76
2004 Mercier GT, Campbell JA, Chappell JD, Stehle T, Dermody TS, Barry MA. A chimeric adenovirus vector encoding reovirus attachment protein sigma1 targets cells expressing junctional adhesion molecule 1. Proceedings of the National Academy of Sciences of the United States of America. 101: 6188-93. PMID 15079060 DOI: 10.1073/pnas.0400542101  0.76
2004 Blum JS, Parrott MB, Mikos AG, Barry MA. Early osteoblastic differentiation induced by dexamethasone enhances adenoviral gene delivery to marrow stromal cells. Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society. 22: 411-6. PMID 15013104 DOI: 10.1016/j.orthres.2003.08.006  0.76
2003 Blum JS, Barry MA, Mikos AG, Jansen JA. In vivo evaluation of gene therapy vectors in ex vivo-derived marrow stromal cells for bone regeneration in a rat critical-size calvarial defect model. Human Gene Therapy. 14: 1689-701. PMID 14670121 DOI: 10.1089/104303403322611719  0.76
2003 Howell DP, Krieser RJ, Eastman A, Barry MA. Deoxyribonuclease II is a lysosomal barrier to transfection. Molecular Therapy : the Journal of the American Society of Gene Therapy. 8: 957-63. PMID 14664798 DOI: 10.1016/j.ymthe.2003.09.011  0.76
2003 Blum JS, Barry MA, Mikos AG. Bone regeneration through transplantation of genetically modified cells. Clinics in Plastic Surgery. 30: 611-20. PMID 14621309 DOI: 10.1016/S0094-1298(03)00079-8  0.76
2003 Parrott MB, Adams KE, Mercier GT, Mok H, Campos SK, Barry MA. Metabolically biotinylated adenovirus for cell targeting, ligand screening, and vector purification. Molecular Therapy : the Journal of the American Society of Gene Therapy. 8: 688-700. PMID 14529842 DOI: 10.1016/S1525-0016(03)00213-2  0.76
2003 Takahashi S, Mok H, Parrott MB, Marini FC, Andreeff M, Brenner MK, Barry MA. Selection of chronic lymphocytic leukemia binding peptides. Cancer Research. 63: 5213-7. PMID 14500347  0.76
2003 Barry MA, Campos SK, Ghosh D, Adams KE, Mok H, Mercier GT, Parrott MB. Biotinylated gene therapy vectors. Expert Opinion On Biological Therapy. 3: 925-40. PMID 12943452 DOI: 10.1517/14712598.3.6.925  0.76
2003 Orson FM, Kinsey BM, Bhogal BS, Song L, Densmore CL, Barry MA. Targeted delivery of expression plasmids to the lung via macroaggregated polyethylenimine-albumin conjugates. Methods in Molecular Medicine. 75: 575-90. PMID 12407765  0.76
Show low-probability matches.